{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:47Z","timestamp":1787010167636,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"abstract":"<jats:p>\n                    This Mendelian randomization (MR) study aims to elucidate the causal pathways between circulating chemokine C-C motif ligand 11 (CCL11) levels and the pathogenesis of polycystic ovary syndrome (PCOS), with a specific focus on the mediating role of dopamine sulfate isomers. Using genome-wide association data from 14,824 European participants (for CCL11 quantitative trait loci) and 2,01,005 individuals (including 1424 PCOS cases), we performed 2-sample MR analyses, with inverse-variance weighting as the primary estimator. Sensitivity analyses included MR-Egger regression and weighted median approaches. Genetic predisposition to elevated CCL11 concentrations was significantly associated with an increased risk of PCOS (odds ratio\u2005=\u20051.28 per standard deviation increase, 95% confidence interval [CI]: 1.04\u20131.58,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.021). Reverse causality analysis showed no significant association (odds ratio\u2005=\u20050.98, 95% CI: 0.95\u20131.01). Two-step mediation MR revealed that 8.8% (95% CI: 2.1\u201315.5%) of CCL11\u2019s effect on PCOS is mediated through altered dopamine 4-sulfate\/3-\n                    <jats:italic toggle=\"yes\">O<\/jats:italic>\n                    -sulfate ratios, indicating partial neuroendocrine mediation. Our findings identify CCL11 as an etiological factor in PCOS development, with dopamine metabolite imbalance representing a novel intermediary pathway. The predominant mechanisms underlying this association require further characterization, necessitating exploration of additional inflammatory and metabolic mediators. These results enhance understanding of chemokine-neuroendocrine interactions in PCOS pathophysiology and highlight potential therapeutic targets.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044448","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:00:48Z","timestamp":1758571248000},"page":"e44448","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["A Mendelian randomization study: Genetically predicted dopamine 4-sulfate to dopamine 3-O-sulfate ratio mediates the association between chemokine C-C motif ligand 11 and polycystic ovary syndrome"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6388-2851","authenticated-orcid":false,"given":"Yanfang","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiake","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250928","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"R2-20250928","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"R3-20250928","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited.","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"R4-20250928","doi-asserted-by":"crossref","first-page":"359","DOI":"10.17219\/acem\/59380","article-title":"The pathogenesis and treatment of polycystic ovary syndrome: what\u2019s new?","volume":"26","author":"Bednarska","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"R5-20250928","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease.","volume":"89","author":"Boulman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20250928","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.fertnstert.2021.05.093","article-title":"Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome.","volume":"116","author":"Juan","year":"2021","journal-title":"Fertil Steril"},{"key":"R7-20250928","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12958-018-0354-x","article-title":"GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile.","volume":"16","author":"Chaudhari","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"R8-20250928","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2012.06.018","article-title":"Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.","volume":"60","author":"Panee","year":"2012","journal-title":"Cytokine"},{"key":"R9-20250928","doi-asserted-by":"crossref","first-page":"106334","DOI":"10.1016\/j.psyneuen.2023.106334","article-title":"The effect of inflammation, SARS-CoV-2 infection, age and mental health on serotonin, and kynurenine and catecholamine pathway metabolites.","volume":"156","author":"H\u00fcfner","year":"2023","journal-title":"Psychoneuroendocrinology"},{"key":"R10-20250928","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R11-20250928","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R12-20250928","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R13-20250928","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R14-20250928","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing.","volume":"467","author":"Abecasis","year":"2010","journal-title":"Nature"},{"key":"R15-20250928","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R16-20250928","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R17-20250928","doi-asserted-by":"crossref","first-page":"252","DOI":"10.12688\/wellcomeopenres.16374.2","article-title":"MendelianRandomization v0.5.0: updates to an R package for performing Mendelian randomization analyses using summarized data.","volume":"5","author":"Broadbent","year":"2020","journal-title":"Wellcome Open Res"},{"key":"R18-20250928","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00394-020-02369-z","article-title":"Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study.","volume":"60","author":"Zhang","year":"2021","journal-title":"Eur J Nutr"},{"key":"R19-20250928","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation.","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"R21-20250928","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"R22-20250928","doi-asserted-by":"crossref","first-page":"884298","DOI":"10.3389\/fcimb.2022.884298","article-title":"Genetic predisposition of anti-cytomegalovirus immunoglobulin G levels and the risk of 9 cardiovascular diseases.","volume":"12","author":"Tan","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R23-20250928","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R24-20250928","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00404-009-1226-6","article-title":"High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.","volume":"281","author":"Verit","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"R25-20250928","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4103\/ijem.IJEM_650_19","article-title":"Serum CCL 18 levels in women with polycystic ovarian syndrome.","volume":"24","author":"Sam","year":"2020","journal-title":"Indian J Endocrinol Metab"},{"key":"R26-20250928","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome.","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"R27-20250928","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system.","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-20250928","first-page":"95","article-title":"Adrenal androgens regulation and adrenopause.","volume":"35","author":"Alesci","year":"2001","journal-title":"Endocr Regul"},{"key":"R29-20250928","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cen.12086","article-title":"Sex hormone binding globulin and insulin resistance.","volume":"78","author":"Wallace","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R30-20250928","first-page":"3979","article-title":"Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene.","volume":"117","author":"Selva","year":"2007","journal-title":"J Clin Invest"},{"key":"R31-20250928","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1210\/en.2005-0902","article-title":"Regulation of hepatic insulin-like growth factor-binding protein-1 gene expression by insulin: central role for mammalian target of rapamycin independent of forkhead box O proteins.","volume":"147","author":"Mounier","year":"2006","journal-title":"Endocrinology"},{"key":"R32-20250928","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4161\/cc.5.11.2803","article-title":"Ovarian steroids: the good, the bad, and the signals that raise them.","volume":"5","author":"Jamnongjit","year":"2006","journal-title":"Cell Cycle"},{"key":"R33-20250928","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tem.2007.07.003","article-title":"Abdominal adiposity and the polycystic ovary syndrome.","volume":"18","author":"Escobar-Morreale","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"R34-20250928","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"R35-20250928","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.steroids.2011.10.013","article-title":"Tissue physiology and pathology of aromatase.","volume":"77","author":"Stocco","year":"2012","journal-title":"Steroids"},{"key":"R36-20250928","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.1993.tb01744.x","article-title":"The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women.","volume":"39","author":"Pasquali","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R37-20250928","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biocel.2011.03.001","article-title":"Cytokines: signalling molecules controlling ovarian functions.","volume":"43","author":"Sirotkin","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"R38-20250928","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/mrd.22285","article-title":"Cytokines in ovarian folliculogenesis, oocyte maturation and luteinisation.","volume":"81","author":"Field","year":"2014","journal-title":"Mol Reprod Dev"},{"key":"R39-20250928","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.2627","article-title":"The cellular and signaling networks linking the immune system and metabolism in disease.","volume":"18","author":"Osborn","year":"2012","journal-title":"Nat Med"},{"key":"R40-20250928","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2010.02.010","article-title":"Tumor necrosis factor alpha (-308), interleukin-6 (-174) and interleukin-10 (-1082) gene polymorphisms in polycystic ovary syndrome.","volume":"150","author":"Vural","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4 Pt 1","key":"R41-20250928","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0895-7061(95)00351-7","article-title":"Dopamine receptor signaling defects in spontaneous hypertension.","volume":"9","author":"Jose","year":"1996","journal-title":"Am J Hypertens"},{"key":"R42-20250928","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1523\/JNEUROSCI.4720-05.2006","article-title":"Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice.","volume":"26","author":"Li","year":"2006","journal-title":"J Neurosci"},{"key":"R43-20250928","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11481-019-09851-4","article-title":"Where is dopamine and how do immune cells see it?: dopamine-mediated immune cell function in health and disease.","volume":"15","author":"Matt","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"R44-20250928","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","article-title":"Dopamine, immunity, and disease.","volume":"75","author":"Channer","year":"2023","journal-title":"Pharmacol Rev"},{"key":"R45-20250928","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome.","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"R46-20250928","doi-asserted-by":"crossref","first-page":"nwab163","DOI":"10.1093\/nsr\/nwab163","article-title":"Sulfation modification of dopamine in brain regulates aggregative behavior of animals.","volume":"9","author":"Chen","year":"2022","journal-title":"Natl Sci Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:00:31Z","timestamp":1759046431000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":45,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044448","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"2025-06-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}